Clinical trial · Observational
Needs Assessment After Cancer in Patients Treated for Breast Cancer
NCT03902964CI-TRIAL-00037925EACEcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
observational monocentric study
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasm Female | — | UNRESOLVED | — |
| Fear Cancer | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- women treated for breast cancer in 2017 (cohort A)
- description
- all patients who completed breast cancer treatment between January 1 and May 31, 2017. Withdrawal of men, metastatic patients from the outset, patients with a history of breast cancer or any other location, selection of 20 patients with breast cancer in situ at random
- label
- women treated for breast cancer in 2015 (cohorte B)
- description
- all patients who completed breast cancer treatment between January 1 and 31 May 2015. Withdrawal of men, metastatic patients from the outset, patients with a history of breast cancer or any other location, selection of 20 patients with breast cancer in situ at random
Primary outcomes (1)
- measure
- Post-cancer needs analysis
- timeFrame
- 2 years
- description
- Post-cancer needs analysis based on the "post-cancer needs assessment" questionnaire for patients in both cohorts
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: Women who have been treated for breast cancer and whose treatment ended in 2017 (cohort A) and in 2015 (cohort B), aged between 18 and 80 years, and who declared their non-opposition free and enlightened. Exclusion Criteria: Patients who have been treated for recurrence or 2nd cancer, metastases from the outset, male, refusal to participate.
References
Publications (0)
Data not yet available
No reference posted for this study.